400-921-8278
| Catalog_no | ADMC0292 |
| Product_name | R306465(JNJ-16241199) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2340.00/8340.00/13880.00 |
| Specificity | Target: See reference. Fields: R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. |
| Dilution | |
| Purification | 97% |
| Concentration | 靶点：See reference;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | R 306465,JNJ16241199,R-306465,JNJ 16241199 |
| Observed_band | 413.11 |
| Notes | R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
